查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948849

生髮補充劑和治療產品市場－全球產業規模、佔有率、趨勢、機會及按類型、地區和競爭格局分類的預測（2021-2031年）

Hair Growth Supplement and Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Supplements, Pharmaceuticals, Devices), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生髮補充劑和治療市場預計將從 2025 年的 76.5 億美元成長到 2031 年的 111.2 億美元，複合年成長率為 6.43%。

該市場涵蓋一系列旨在促進頭皮健康和激活毛囊的治療設備、營養補充劑和藥物製劑。主要成長要素包括全球老化人口中男性型脫髮症的日益普遍，以及人們對個人外表日益成長的心理關注。這導致人們越來越傾向於尋求在脫髮早期階段就進行治療以逆轉脫髮。此外，飲食習慣的改變和壓力水平的上升也擴大了潛在消費群體，從而催生了對傳統使用者群體之外的有效治療方法的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 76.5億美元
市場規模：2031年 111.2億美元
複合年成長率：2026-2031年 6.43%
成長最快的細分市場 補充
最大的市場 北美洲

近期產業數據顯示，消費者對維持容顏活力有著濃厚的興趣。例如，責任營養委員會 (CRN) 的報告指出，到 2024 年，美國 26% 的膳食補充劑使用者將服用專門用於促進皮膚、頭髮和指甲健康的保健產品。儘管需求持續旺盛，但由於新藥監管標準嚴格，市場仍面臨許多挑戰。這些嚴苛的要求顯著延長了核准流程，可能延緩創新臨床療法的商業化。

市場促進因素

直接面對消費者 (DTC) 的電子商務平台蓬勃發展，個人化治療方案日益普及，從根本上改變了市場的可及性。透過利用遠距遠端醫療服務，企業現在可以直接向消費者提供客製化的營養保健品和處方級脫髮解決方案，從而有助於減少尋求治療所帶來的恥辱感。這種模式透過根據個人生理需求量身定做的訂閱模式，有效提升了客戶維繫，並擴大了市場覆蓋範圍。 Hims & Hers Health, Inc. 就是這趨勢的有力佐證。該公司在 2024 年 11 月發布的「2024 年第三季財務業績」中，宣布其訂閱用戶創下 200 萬的歷史新高。這項里程碑式的成就主要得益於對個人化醫療解決方案的需求，凸顯了向數位化健康管理的轉變，便利性有助於提高治療依從性。

同時，非侵入性治療方法技術的進步以及針對以往未被滿足的醫療需求的新型藥物的研發正在推動市場發展。該行業日益採用先進的免疫調節和生物技術治療方法，尤其是在脫髮症等自體免疫疾病領域，而創業投資正支持這些治療方法上市。例如，在2024年2月題為「Pelage Pharmaceuticals宣布完成1,675萬美元A輪資金籌措」的新聞稿中，Perage Pharmaceuticals宣布已獲得PP405的研發資金，PP405是一種活化休眠毛囊幹細胞的外用藥物。這些投資也得到了監管部門成功核准的支持。例如，美國食品藥物管理局（FDA）於2024年核准了Sun Pharmaceutical Industries的LEQSELVI（用於治療重度脫髮症），這大大擴展了可用的治療選擇。

市場挑戰

對新藥產品嚴格的監管要求是全球生髮補充劑和治療市場發展的一大障礙。監管機構採用嚴格的測試通訊協定以確保產品的安全性和有效性，這不可避免地延長了新療法的研發週期。漫長的核可階段導致創新速度與實際上市速之間存在差距，迫使企業在無法產生收入的情況下長期投入資金。因此，先進配方的上市往往被推遲，限制了產業推出能夠提升市場價值的新一代療法的能力。

鑑於尋求毛髮修復服務的人數迅速成長，這種監管瓶頸尤其具有限制性。根據國際毛髮重建外科學會預測，到2024年，每位會員醫生的平均患者數量預計將比2021年成長20%，這表明市場對有效治療方法的需求強勁。然而，監管方面的延誤阻礙了新型藥物解決方案充分利用這一需求，使得該行業難以透過先進的產品上市，將消費者日益成長的興趣立即轉化為收入。

市場趨勢

隨著消費者越來越重視整體健康和安全，而非依賴合成藥物療法，潔淨標示、純素和植物來源處方箋在市場上取得了顯著成長。為了順應這一偏好轉變，護髮產品正在重新設計，去除人工添加劑和激素，並採用標準化的植物成分來解決壓力等根本原因，同時避免有害的副作用。領先天然品牌的持續出色表現，印證了這種向無藥物功效方向轉變的成功。例如，聯合利華於2025年8月發布的《重返2025年上半年報告》指出，其旗下以植物來源品牌Nutrafol為首的健康事業部連續21個季度實現了強勁的兩位數成長，凸顯了消費者對天然、經科學驗證的解決方案日益成長的需求。

同時，臨床級家用生髮設備的普及，使得以往只有專科診所才能享受到的先進再生療法變得更加大眾化。技術的微型化使得穿戴式裝置得以大規模生產，這些裝置採用先進的LED和低功率雷射療法（LLLT），讓使用者能夠將專業級的效果與便捷的自主使用體驗結合。隨著越來越多的消費者尋求經濟實惠、非侵入性的替代方案，以取代長期藥物治療和手術，該領域正在迅速發展。根據The Industry.beauty網站2025年9月發表的一篇報導《美容科技集團目標IPO估值3.2億英鎊》報道，美容科技集團（Beauty Tech Group）在2025會計年度上半年實現了27%的銷售額成長，達到5520萬英鎊。這項成長主要得益於該公司家用生髮設備在全球的普及。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章：全球生髮補充劑和治療產品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（膳食補充劑、藥品、醫療設備）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美生髮補充劑和治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲生髮補充劑和治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區生髮補充劑和治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲生髮補充劑和治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲生髮補充劑和治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球生髮補充品與治療產品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Nutraceutical Wellness Inc.
  • Viviscal Limited.
  • GNC Holdings, Inc.
  • Procter & Gamble
  • InVite Health
  • Johnson & Johnson Services, Inc
  • Merck & Co., Inc.
  • Curallux, LLC.
  • iRestore Hair Growth System
  • Lexington International, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19445

The Global Hair Growth Supplement and Treatment Market is projected to expand from USD 7.65 Billion in 2025 to USD 11.12 Billion by 2031, reflecting a compound annual growth rate of 6.43%. This market sector comprises a wide variety of therapeutic devices, dietary supplements, and pharmaceutical formulations aimed at enhancing scalp health and stimulating hair follicles. Key growth drivers include a globally aging demographic increasingly prone to androgenetic alopecia, alongside a growing psychological focus on personal aesthetics that encourages individuals to pursue restorative treatments earlier in the thinning process. Additionally, shifting dietary patterns and rising stress levels have widened the potential consumer base, creating a need for effective remedies that extend beyond traditional user groups.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 7.65 Billion
Market Size 2031USD 11.12 Billion
CAGR 2026-20316.43%
Fastest Growing SegmentSupplements
Largest MarketNorth America

Recent industry data highlights a strong consumer dedication to maintaining aesthetic vitality. For instance, the Council for Responsible Nutrition reported that in 2024, 26% of dietary supplement users in the United States consumed products specifically meant to support the health of skin, hair, and nails. Despite this persistent demand, the market faces substantial obstacles due to rigorous regulatory standards for new pharmaceutical agents. These stringent requirements can extend approval timelines significantly, thereby slowing the commercialization of innovative clinical treatments.

Market Driver

The growth of direct-to-consumer e-commerce platforms and the rising uptake of personalized treatment plans are fundamentally transforming market accessibility. By utilizing telemedicine services, companies can now deliver customized nutraceuticals and prescription-strength hair loss solutions directly to consumers, helping to minimize the stigma often attached to seeking treatment. This approach promotes high customer retention through subscription models tailored to individual physiological requirements, effectively expanding the market reach. As evidence of this trend, Hims & Hers Health, Inc. reported in their 'Third Quarter 2024 Financial Results' in November 2024 that their subscriber base had reached a record 2.0 million, a milestone largely driven by the appetite for personalized health solutions, confirming a shift toward digital health management where convenience drives adherence.

Simultaneously, the market is being propelled by technological breakthroughs in non-invasive restoration and the development of novel pharmaceutical agents that target previously unmet medical needs. The industry is increasingly adopting sophisticated immunomodulatory and biotechnology-based treatments, specifically for autoimmune disorders such as alopecia areata, supported by venture capital funding dedicated to bringing these mechanisms to market. For example, Pelage Pharmaceuticals announced in a February 2024 press release titled 'Pelage Pharmaceuticals Announces $16.75 Million Series A Financing' that it had secured funding to develop PP405, a topical treatment aimed at reactivating dormant hair follicle stem cells. These investments are further validated by regulatory successes, such as the U.S. FDA's 2024 approval of Sun Pharmaceutical Industries Ltd.'s LEQSELVI for severe alopecia areata, which has significantly broadened the available therapeutic options.

Market Challenge

Rigorous regulatory mandates regarding novel pharmaceutical agents represent a major hurdle for the Global Hair Growth Supplement and Treatment Market. Regulatory bodies enforce strict testing protocols to ensure both safety and efficacy, a process that inevitably extends the development timeline for new clinical therapies. This protracted approval phase creates a gap between the speed of innovation and actual market availability, compelling companies to sustain long periods of capital spending without generating revenue. Consequently, the launch of advanced formulations is often postponed, restricting the industry's capacity to debut next-generation therapies that could otherwise enhance market valuation.

This regulatory bottleneck is particularly constraining given the rapidly increasing number of individuals seeking restoration services. According to the International Society of Hair Restoration Surgery, the average patient volume per member physician rose by 20% in 2024 compared to 2021 levels, indicating a strong desire for effective treatments. However, because regulatory slowdowns hinder the market from fully capitalizing on this demand with new pharmaceutical solutions, the industry finds it difficult to immediately translate this heightened consumer interest into revenue through advanced product introductions.

Market Trends

The market is experiencing a notable rise in clean label, vegan, and plant-based formulations as consumers increasingly value holistic wellness and safety over synthetic pharmacotherapy. This preference is prompting the reformulation of hair health products to eliminate artificial additives and hormones, utilizing standardized botanicals instead to address root causes such as stress without causing adverse side effects. The success of this shift toward drug-free efficacy is demonstrated by the enduring performance of major natural brands; for instance, Unilever's 'What's behind Unilever's first half results?' report from August 2025 noted that its Wellbeing business group, led by the plant-based brand Nutrafol, achieved strong double-digit growth for the 21st consecutive quarter, underscoring the demand for nature-derived, scientifically validated solutions.

In parallel, the widespread availability of clinical-grade at-home hair growth devices is democratizing access to advanced restoration therapies that were once limited to professional clinics. Technological miniaturization has facilitated the mass production of sophisticated LED and low-level laser therapy (LLLT) wearables, providing users with professional-level results alongside the convenience of autonomous use. This sector is growing rapidly as consumers look for cost-effective, non-invasive alternatives to long-term medication or surgical procedures. According to an article by The Industry.beauty in September 2025 titled 'Beauty Tech Group targets £320m valuation ahead of stock market debut', the Beauty Tech Group saw sales increase by 27% to £55.2 million in the first half of 2025, a growth spur fueled by the rising global adoption of its at-home hair restoration devices.

Key Market Players

  • Nutraceutical Wellness Inc.
  • Viviscal Limited.
  • GNC Holdings, Inc.
  • Procter & Gamble
  • InVite Health
  • Johnson & Johnson Services, Inc
  • Merck & Co., Inc.
  • Curallux, LLC.
  • iRestore Hair Growth System
  • Lexington International, LLC

Report Scope

In this report, the Global Hair Growth Supplement and Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hair Growth Supplement and Treatment Market, By Type

  • Supplements
  • Pharmaceuticals
  • Devices

Hair Growth Supplement and Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hair Growth Supplement and Treatment Market.

Available Customizations:

Global Hair Growth Supplement and Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hair Growth Supplement and Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Supplements, Pharmaceuticals, Devices)
    • 5.2.2. By Region
    • 5.2.3. By Company (2025)
  • 5.3. Market Map

6. North America Hair Growth Supplement and Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hair Growth Supplement and Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
    • 6.3.2. Canada Hair Growth Supplement and Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
    • 6.3.3. Mexico Hair Growth Supplement and Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type

7. Europe Hair Growth Supplement and Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hair Growth Supplement and Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
    • 7.3.2. France Hair Growth Supplement and Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
    • 7.3.3. United Kingdom Hair Growth Supplement and Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
    • 7.3.4. Italy Hair Growth Supplement and Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
    • 7.3.5. Spain Hair Growth Supplement and Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type

8. Asia Pacific Hair Growth Supplement and Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hair Growth Supplement and Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
    • 8.3.2. India Hair Growth Supplement and Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
    • 8.3.3. Japan Hair Growth Supplement and Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
    • 8.3.4. South Korea Hair Growth Supplement and Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
    • 8.3.5. Australia Hair Growth Supplement and Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type

9. Middle East & Africa Hair Growth Supplement and Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hair Growth Supplement and Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
    • 9.3.2. UAE Hair Growth Supplement and Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
    • 9.3.3. South Africa Hair Growth Supplement and Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type

10. South America Hair Growth Supplement and Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hair Growth Supplement and Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
    • 10.3.2. Colombia Hair Growth Supplement and Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
    • 10.3.3. Argentina Hair Growth Supplement and Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hair Growth Supplement and Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Nutraceutical Wellness Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Viviscal Limited.
  • 15.3. GNC Holdings, Inc.
  • 15.4. Procter & Gamble
  • 15.5. InVite Health
  • 15.6. Johnson & Johnson Services, Inc
  • 15.7. Merck & Co., Inc.
  • 15.8. Curallux, LLC.
  • 15.9. iRestore Hair Growth System
  • 15.10. Lexington International, LLC

16. Strategic Recommendations

17. About Us & Disclaimer